Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for Autolus Therapeutics (AUTL) over the last 8 years, with Q3 2025 value amounting to 0.45%.

  • Autolus Therapeutics' Return on Capital Employed fell 1700.0% to 0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.47% for FY2024, which is 0.0% changed from last year.
  • Autolus Therapeutics' Return on Capital Employed amounted to 0.45% in Q3 2025, which was down 1700.0% from 0.41% recorded in Q2 2025.
  • Autolus Therapeutics' 5-year Return on Capital Employed high stood at 0.23% for Q2 2024, and its period low was 0.58% during Q1 2021.
  • In the last 5 years, Autolus Therapeutics' Return on Capital Employed had a median value of 0.35% in 2023 and averaged 0.38%.
  • In the last 5 years, Autolus Therapeutics' Return on Capital Employed skyrocketed by 3100bps in 2021 and then tumbled by -1700bps in 2025.
  • Over the past 5 years, Autolus Therapeutics' Return on Capital Employed (Quarter) stood at 0.31% in 2021, then decreased by -20bps to 0.38% in 2022, then tumbled by -38bps to 0.52% in 2023, then soared by 38bps to 0.32% in 2024, then crashed by -39bps to 0.45% in 2025.
  • Its Return on Capital Employed was 0.45% in Q3 2025, compared to 0.41% in Q2 2025 and 0.38% in Q1 2025.